Mitochondria as pharmacological targets.
In the last decade, mitochondria have provided a vast area of research for the pharmacologist, with a wealth of potential targets for drug action. Correct target identification and subsequent pharmacological manipulation might greatly help in the prevention and/or treatment of a number of the most prevalent diseases of our time including cancer, neurodegenerative disease and myocardial infarction. This is a commentary to accompany the publication of three papers in this issue of the BJP by Kurz et al., Pravdic et al. and Puerta et al. on different aspects of pharmacology involving mitochondria.
Moncada
S
S
The Wolfson Institute for Biomedical Research, University College London, UK. s.moncada@ucl.ac.uk <s.moncada@ucl.ac.uk>
D000818:Animals; D016503:Drug Delivery Systems; D006801:Humans; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D019636:Neurodegenerative Diseases / Q000188:drug therapy / Q000503:physiopathology; D015398:Signal Transduction / Q000187:drug effects